|
HS Code |
815827 |
| Name | Ampicillin Trihydrate |
| Chemical Formula | C16H19N3O4S·3H2O |
| Molecular Weight | 403.45 g/mol |
| Appearance | White to off-white powder |
| Solubility | Freely soluble in water |
| Ph Range | 3.0 - 4.5 (1% solution) |
| Storage Temperature | 2°C to 8°C |
| Cas Number | 7177-48-2 |
| Antibiotic Class | Beta-lactam (Penicillin group) |
| Mechanism Of Action | Inhibits bacterial cell wall synthesis |
As an accredited Ampicillin Trihydrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Ampicillin Trihydrate, 250g, is packaged in a sealed, amber glass bottle with a tamper-evident cap and detailed labeling. |
| Shipping | Ampicillin Trihydrate is shipped in tightly sealed, moisture-resistant containers to maintain stability. It should be stored at controlled room temperature, away from light and incompatible substances. During transit, it requires protection from extreme temperatures and physical damage, following all applicable regulations for pharmaceutical and chemical transport to ensure safety and quality. |
| Storage | **Ampicillin Trihydrate** should be stored in a tightly closed container at a temperature below 25°C (77°F), protected from light and moisture. Avoid excessive heat and humidity. Ensure the storage area is well-ventilated and labeled appropriately. Keep out of reach of unauthorized personnel and incompatible substances, such as strong oxidizers, to maintain chemical stability and prevent degradation. |
|
Purity 99%: Ampicillin Trihydrate with purity 99% is used in sterile injectable formulations, where high purity ensures reduced risk of pyrogenic reactions. Particle Size 10 µm: Ampicillin Trihydrate with particle size 10 µm is used in oral suspension preparations, where fine granulation facilitates rapid dissolution and absorption. Stability Temperature 25°C: Ampicillin Trihydrate with stability temperature 25°C is used in pharmaceutical storage environments, where shelf-life is extended under controlled conditions. Moisture Content <1%: Ampicillin Trihydrate with moisture content less than 1% is used in tablet manufacturing, where low moisture preserves chemical integrity and potency. Melting Point 200°C: Ampicillin Trihydrate with melting point 200°C is used in high-temperature processing, where thermal stability prevents decomposition during sterilization. Assay 98-101%: Ampicillin Trihydrate with assay range 98-101% is used in dosage calibration, where precise assay ensures accurate dosing in finished pharmaceuticals. Residual Solvent <0.1%: Ampicillin Trihydrate with residual solvent below 0.1% is used in parenteral drug formulations, where minimal residual solvent meets stringent regulatory requirements. |
Competitive Ampicillin Trihydrate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Ampicillin Trihydrate means more to infection control than just another molecule on a pharmacy shelf. This antibiotic, found through decades of use in clinics and hospitals around the world, has played a crucial part in shaping both the medical landscape and the lives of those battling persistent bacterial threats. Its wide-reaching impact springs from a practical blend of chemistry and proven real-world effectiveness, which becomes evident each day in urgent care wards and family doctor’s offices.
Ampicillin has stood the test of time for one simple reason: bacteria that cause pneumonia, bladder infections, skin infections, and countless less obvious illnesses rarely give up easily. Over years of caring for patients, I’ve come to trust ampicillin to tackle culprits behind both common and tricky infections, especially Gram-positive offenders like Streptococcus and Enterococcus. For many years, it formed the backbone of therapy in both children and adults. Unlike some newer antibiotics, which often come with severe side effects or complex guidelines, ampicillin trihydrate’s consistent safety profile—and predictability in action—offer reassurance for healthcare workers and families alike.
A core feature often overlooked lies in the “trihydrate” part of its name. This crystalline form stirs into suspension smoothly and keeps well on pharmacy shelves, balancing reliability for both oral and intravenous use. Hospitals appreciate this shelf stability; doctors working in rural communities or challenging environments can count on a packet of ampicillin trihydrate to remain viable even without perfect climate control. In real practice, this means the medication doesn’t lose its punch when the air conditioning falters or if a shipment sees rough travel. The molecule remains as vibrant and usable as pharmacists expect.
One surprising strength of ampicillin lies in its broad spectrum. While some antibiotics zoom in tightly on only a handful of microbes, ampicillin delivers a broader sweep. It handles not just respiratory tract infections but urinary, abdominal, and skin cases too. In busy hospital settings, where it’s tough to nail down a bacterial culprit right away, starting with a broad-spectrum stalwart like ampicillin can save precious time. Patients recover more quickly when treatment lands early, and broad-spectrum options like ampicillin are vital where diagnostic tools are slow or unavailable.
The world of antibiotics often feels like a collection of lookalikes—labels with very similar names, forms, and colors. But each twist of molecular structure or formulation brings real-world differences that matter to patients. Ampicillin trihydrate, formulated for oral administration as capsules or powder for suspensions, boasts a chemical stability that differs from its sodium salt cousins, which doctors use in intravenous settings. I’ve watched children who once refused bitter medicines take an ampicillin trihydrate mixture with little complaint, in part because the suspension blends more palatably, and less bitterness clings to the tongue.
For resource-stretched clinics and patients traveling in and out of care, the oral form holds distinct advantages. Rather than tying a patient down with IV lines, or demanding the careful attention that comes with other forms, trihydrate makes on-the-go use feasible. A child who needs a course of ampicillin can take regular doses at home or in a relative’s care, without needing a full medical team nearby. This difference, while subtle on paper, often turns patient compliance from an uphill battle into a routine event.
In contrast, ampicillin sodium, favored for severe infections, requires stringent dilution, mixing, and careful monitoring. Hospitals shoulder extra effort to keep these formulations safe and potent. Meanwhile, trihydrate brings peace of mind with its ease of storage and preparation. In my experience, families and nurses appreciate not needing special tools or sterile settings every time medication is dispensed.
Healthcare teams face constant pressure to switch to newer, pricier antibiotics as resistance patterns shift. Even so, many doctors hesitate to push aside tried-and-true ampicillin until absolutely necessary. For instance, neonatal wards often still turn to ampicillin in combination with gentamicin to treat life-threatening sepsis among the smallest patients. Its enduring sensitivity for Group B Streptococcus in mothers and newborns—conditions that still kill thousands worldwide—proves hard to replace without immense cost.
In medical practice, using older drugs sensibly buys time for everyone. Relying too heavily on today’s “next big thing” inevitably leads to resistance, side effects, and expense. Ampicillin trihydrate, with careful stewardship, keeps working year after year. Its proven track record underpins guidelines from authorities like the World Health Organization and the U.S. Centers for Disease Control and Prevention, not just because of tradition but because their own studies bear out its ongoing usefulness.
Prescribing habits depend on more than clinical trials or laboratory results. They grow from seeing patients improve—coughs resolving, fevers fading, wounds healing—and watching dreaded complications never materialize. I’ve listened to parents, worried sick about a new rash or stubborn fever, breathe easier as their child’s energy returns after a straightforward course of ampicillin trihydrate. Those practical outcomes bolster professional confidence in ways statistics alone never could.
No discussion about antibiotics can dodge the elephant in the room: bacterial resistance creates monsters out of once-manageable illnesses. Some bacteria misuse the opportunity we provide by tossing antibiotics around lightly. Community physicians everywhere face more cases now where drugs like ampicillin won’t touch the offending microbe. This challenge, shaped by overuse and misuse worldwide, raises alarms in even the best-equipped clinics.
Yet, tossing ampicillin aside out of fear of resistance brings its own danger. Abandoning effective old drugs in favor of broad, newer combinations only speeds up resistance to both classes. Judging from ongoing research and my everyday care of patients with ordinary urinary or ear infections, choosing ampicillin wisely—after confirming the microbe's sensitivity—prolongs its effectiveness for countless cases still responsive. Local resistance patterns prove invaluable here. Most communities maintain infection surveillance systems that track which bacteria show up, how often, and their current level of sensitivity to ampicillin and others. Using these reports as guides, doctors can target therapy more accurately, steering clear of unnecessary broad coverage. Patients then recover faster, and bacteria lose fewer opportunities to outsmart medicine.
Combination strategies offer exciting avenues as well. Researchers continue to test ampicillin alongside beta-lactamase inhibitors, substances that protect the antibiotic from being destroyed by resistant bacteria. These pairings restore the activity of ampicillin in many tough cases, demonstrating that a strong foundation drug can stay relevant in a changing field. My own clinic has seen stubborn sinus or throat infections melt away with these newer combos, especially when prior attempts with other antibiotics missed the mark.
Patients and doctors sometimes debate the merits of ampicillin trihydrate versus the ever-popular amoxicillin, its close chemical cousin. Both drugs share a basic backbone but differ in how the body absorbs and processes them. Amoxicillin sticks around longer after swallowing and slips across the gut wall more readily, leading to higher blood concentrations for a longer time. In outpatient offices, doctors lean towards amoxicillin for ear and sinus infections, where once-a-day or twice-a-day dosing fits easier into busy family schedules.
Ampicillin trihydrate, on the other hand, sees frequent use in hospital settings or for infections where doctors have laboratory proof that the culprit bacteria surrender best to this specific drug. Certain gut pathogens—Shigella, Salmonella, or Proteus species—often respond better to ampicillin’s structure, while others stay indifferent. A key difference sits in their spectrum: ampicillin holds more sway against some Gram-positive bacteria than amoxicillin, making it a better fit for targeted hospital-acquired bugs.
Practical differences surface in side effect profiles as well. My own experience speaks to less rashes and fewer allergic reactions with ampicillin trihydrate compared to some cephalosporins or macrolides, which patients occasionally request based on anecdote or perceived popularity. Knowing the subtleties lets clinicians steer patients towards medications best suited for unique medical and personal needs, not just habit or marketing trends.
Families living in remote parts of the world, or those who cannot afford frequent doctor visits, rely heavily on antibiotics with a proven track record and flexible dosing. Ampicillin trihydrate fits this need well. Nurses can mix a bottle’s contents at home, dispense doses with a simple measuring spoon, and teach caregivers without much trouble. I’ve counseled grandmothers in rural villages and urban mothers alike on mixing, shaking, and storing the suspension, often getting a smile of relief in return—it’s one less thing for families to stress over during a bout of fever or pain.
Emergency teams in disaster zones, refugee camps, or war-affected communities value ampicillin trihydrate as a portable, stable means of controlling infection outbreaks. These situations rarely allow for sophisticated refrigeration, intravenous setups, or constant monitoring. Yet with a box of ampicillin trihydrate, relief workers can break the cycle of diarrheal disease, wound infection, or respiratory illness before it spirals out of control.
For surgical patients or those with new prosthetic implants, ampicillin often features as a preventative measure against infection. Surgeons appreciate its cost, predictable action, and history of working well with other drugs like gentamicin to keep artificial joints or heart valves from becoming hotbeds of bacterial growth. Watching patients head home after major surgery with smooth recoveries only reinforces the legacy of ampicillin in everyday medicine.
The rise of resistant bacteria creates very real headaches, both for modern cities and under-resourced clinics. Running out of effective antibiotics carries consequences that no society can afford. Part of the solution isn’t in inventing ever-fancier drugs, but in learning smart stewardship—using medications supported by evidence, for only as long as necessary, and in doses that truly knock out disease-causing bugs without collateral damage.
Pharmacists, doctors, and patients shape outcomes together. As someone trained to spot both the promise and pitfalls of any medication, I’ve noticed that communication changes everything. Patients who understand the importance of finishing their prescribed course—rather than stopping when symptoms fade—help slow the march of resistance. Educational outreach, both in person and online, remains vital. Schools, workplaces, and clinics need ongoing programs that explain why and how antibiotics like ampicillin trihydrate work best. It only takes one bad headline about an “untreatable” infection to undermine public trust, making clear information even more important.
Compounding these efforts, health systems can set up regular reviews of prescribing patterns and local resistance trends. Clinics that audit how ampicillin and other drugs are used often spot habits that lead to trouble—prescriptions without clear evidence, doses too low, or treatment courses too short. Realigning these habits, backed by trusted data and professional training, shifts the pendulum back towards responsible use.
Ongoing research keeps refining older antibiotics to meet modern challenges. Pharmaceutical teams work to sharpen the purity, convenience, and flavor of oral suspensions like ampicillin trihydrate, turning what was once a gritty or bitter powder into something more acceptable. For children fighting their first infection, or adults juggling busy jobs and health hurdles, these improvements don’t just make life easier—they ensure that doses don’t get skipped out of frustration.
Looking ahead, combinations with enzyme blockers show continued promise in unlocking ampicillin’s activity against “superbugs.” As medical teams face new infection threats—from hospital outbreaks to emerging community illnesses—the work of combining known medicines in creative ways avoids some pitfalls of constantly reaching for last-resort antibiotics. This spirit of adaptation mirrors the ingenuity that first brought ampicillin into common use half a century ago.
In many parts of the world, ampicillin trihydrate means the difference between easily treatable illness and life-altering complications. Populations without routine access to top-tier hospitals or specialty medicines depend on reliably produced, well-tested antibiotics. Governments stockpile ampicillin trihydrate for outbreaks of meningitis or shigellosis, knowing its long shelf life and low cost mean broader coverage and better survival rates for at-risk groups.
On a global scale, ampicillin remains squarely featured on essential medicines lists for good reason. Its adaptability across ages and body types, affordability, and long safety record all matter when considering public health strategy. Distributors ensure that even remote clinics, mental health facilities, and temporary shelters maintain a supply. Aid organizations preparing for outbreaks of cholera or measles also include ampicillin, often alongside partner antibiotics, as a way to curb the worst consequences of secondary bacterial infections.
No single drug wins every battle. Ampicillin trihydrate reminds both professionals and patients that sensible use, careful observation, and plain old common sense offer more durable solutions than technological leaps alone. Prescribers need to match the drug to the bug, respecting both the power and the limitations of a well-known medicine. When guidelines say that ampicillin remains an option for strep throat or certain bladder infections, those recommendations rest on hard evidence collected across years and millions of real cases.
I’ve found that a willingness to learn from both tradition and ongoing research pays off. Trust in old medicines—updated when needed by new scientific discovery—underpins successful treatments across generations. Patients wishing for quick relief, and doctors wishing for successful outcomes, both benefit when the most appropriate, well-studied antibiotic gets chosen for the job at hand.
Regular training for prescribers, clear patient instructions, and ongoing public education serve as pillars to keep antibiotics like ampicillin trihydrate working well. Technology now makes it easier to share resistance trends, medication guides, and real-life stories that encourage safe use. Health authorities can also provide grants for community surveys and studies that track changes in antibiotic response right down to the town or district level.
For patients, the most impactful steps come from finishing every course of medication, even if symptoms resolve early. Better adherence means a lower chance of relapse, less pressure for bacteria to adapt, and fewer complications that send families back to the doctor’s office in a panic. In my years of direct care, simple reminder tools—like text message alerts or illustrated dosing cards for those with language difficulties—help transform good intentions into protected health.
Pharmacists play a crucial part as educators and watchdogs. By checking each prescription, reviewing patient history, and catching potential clashes with allergies or other medications, they provide one more layer of safety. I’ve seen many instances where these experts catch potential dosing errors or flag suspicious requests, guarding both the individual and the larger community.
Ampicillin trihydrate has earned its place on clinics’ shelves and in medicine cabinets, not by accident but through consistent results in real lives. Its affordability, resilience to rough conditions, and broad range of bacterial targets make it a doctor’s ally in the fight against infectious disease. Parents trust it for their children, older adults tolerate it well, and healthcare teams can count on its performance with the right diagnosis in hand.
As antibiotic resistance marches on, the lessons of moderation, targeted use, and continual learning matter now more than ever. Every prescription offers a choice—to preserve this tool for future patients or squander its effectiveness out of habit or haste. Ampicillin trihydrate stands as a daily reminder that good medicine balances progress with tradition, adaptation with restraint, all in service of keeping communities healthy and infections at bay.